JP2017526651A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017526651A5 JP2017526651A5 JP2017503611A JP2017503611A JP2017526651A5 JP 2017526651 A5 JP2017526651 A5 JP 2017526651A5 JP 2017503611 A JP2017503611 A JP 2017503611A JP 2017503611 A JP2017503611 A JP 2017503611A JP 2017526651 A5 JP2017526651 A5 JP 2017526651A5
- Authority
- JP
- Japan
- Prior art keywords
- allulose
- less
- tablet
- dry weight
- compressible composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 claims 24
- 239000000203 mixture Substances 0.000 claims 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- 238000002425 crystallisation Methods 0.000 claims 4
- 230000008025 crystallization Effects 0.000 claims 4
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 claims 3
- 238000007907 direct compression Methods 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 235000003599 food sweetener Nutrition 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000000324 neuroprotective effect Effects 0.000 claims 1
- 230000035790 physiological processes and functions Effects 0.000 claims 1
- 239000003642 reactive oxygen metabolite Substances 0.000 claims 1
- 230000002000 scavenging effect Effects 0.000 claims 1
- 238000007873 sieving Methods 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
- 239000003765 sweetening agent Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14306180.2 | 2014-07-21 | ||
| EP14306180 | 2014-07-21 | ||
| PCT/IB2015/001303 WO2016012854A1 (en) | 2014-07-21 | 2015-07-16 | Sugar compositions for tableting by direct compression |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017526651A JP2017526651A (ja) | 2017-09-14 |
| JP2017526651A5 true JP2017526651A5 (enExample) | 2018-08-23 |
| JP6803325B2 JP6803325B2 (ja) | 2020-12-23 |
Family
ID=51265636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017503611A Active JP6803325B2 (ja) | 2014-07-21 | 2015-07-16 | アルロースの製造方法及び錠剤の製造方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10342247B2 (enExample) |
| EP (1) | EP3171710B1 (enExample) |
| JP (1) | JP6803325B2 (enExample) |
| KR (1) | KR102501024B1 (enExample) |
| CN (1) | CN106535661B (enExample) |
| BR (1) | BR112017001192B1 (enExample) |
| CA (1) | CA2955849C (enExample) |
| CL (1) | CL2017000136A1 (enExample) |
| ES (1) | ES3060158T3 (enExample) |
| MX (1) | MX378866B (enExample) |
| SG (1) | SG11201700451QA (enExample) |
| WO (1) | WO2016012854A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017158534A (ja) * | 2016-03-07 | 2017-09-14 | 焼津水産化学工業株式会社 | チップ状食品の製造方法及びチップ状食品 |
| CA3222567A1 (en) | 2016-10-28 | 2018-05-03 | Tate & Lyle Solutions Usa Llc | Method for producing allulose crystals |
| US12590116B2 (en) | 2016-10-28 | 2026-03-31 | Tate & Lyle Solutions Usa Llc | Method for producing allulose crystals |
| FR3061415B1 (fr) * | 2017-01-05 | 2021-07-16 | Roquette Freres | Sirops non cristallisables de d-allulose |
| FR3061414B1 (fr) * | 2017-01-05 | 2021-07-16 | Roquette Freres | Sirops cristallisables de d-allulose |
| FR3061413B1 (fr) * | 2017-01-05 | 2021-08-27 | Roquette Freres | Procede de fabrication de cristaux de d-allulose |
| CN106955290A (zh) * | 2017-03-24 | 2017-07-18 | 南京顺昌医药科技有限公司 | 一种治疗退化性疾病的组合物及其用途 |
| WO2019004555A1 (ko) * | 2017-06-30 | 2019-01-03 | 주식회사 삼양사 | 결정형 기능성 감미료 |
| WO2019004554A1 (ko) * | 2017-06-30 | 2019-01-03 | 주식회사 삼양사 | 결정형 기능성 감미료의 제조방법 |
| KR101988442B1 (ko) | 2017-06-30 | 2019-06-12 | 주식회사 삼양사 | 결정형 기능성 감미료 |
| EP3753945A4 (en) * | 2018-02-12 | 2021-12-01 | Samyang Corporation | PROCESS FOR PRODUCING A CRYSTALLINE FUNCTIONAL SWEETENER |
| AU2020347662A1 (en) * | 2019-09-13 | 2022-03-31 | Meiji Co., Ltd. | Solid food and solid milk |
| EP3864966A1 (de) * | 2020-02-12 | 2021-08-18 | Savanna Ingredients GmbH | Orale zubereitungen mit kristalliner allulose |
| EP4000419A1 (de) | 2020-11-23 | 2022-05-25 | Savanna Ingredients GmbH | Trocknung von allulosekristallen |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT77919B (en) | 1983-01-07 | 1986-04-16 | Tate & Lyle Plc | Process for the production of solid fructose |
| US4692514A (en) | 1985-12-20 | 1987-09-08 | Uop Inc. | Process for separating ketoses from alkaline- or pyridine-catalyzed isomerization products |
| FI104787B (fi) | 1989-06-07 | 2000-04-14 | Xyrofin Oy | Fruktoosipohjainen rakeistettu tuote ja menetelmä sen valmistamiseksi |
| AU718658B2 (en) * | 1996-04-16 | 2000-04-20 | Bayer Aktiengesellschaft | D-mannitol and its preparation |
| FI110095B (fi) * | 1998-05-18 | 2002-11-29 | Xyrofin Oy | Ksylitolin kiteyttäminen, kiteinen ksylitolituote ja sen käyttö |
| JP4473980B2 (ja) * | 1999-06-24 | 2010-06-02 | 株式会社林原生物化学研究所 | 糖質複合体結晶とその製造方法 |
| CN1668735A (zh) | 2002-05-22 | 2005-09-14 | 国立大学法人香川大学 | 稀有糖的生物活性的利用方法及配合了稀有糖的组合物 |
| WO2005060937A1 (en) * | 2003-12-23 | 2005-07-07 | Chr. Hansen A/S | Compressed tablets comprising viable probiotic microorganisms |
| JP4761424B2 (ja) | 2004-03-17 | 2011-08-31 | 株式会社希少糖生産技術研究所 | Ｌ−プシコース結晶、その製造方法および、糖試薬キット |
| GT200600008A (es) | 2005-01-18 | 2006-08-09 | Formulacion de compresion directa y proceso | |
| US8748589B2 (en) | 2005-03-04 | 2014-06-10 | National University Corporation Kagawa University | Complex crystalline sugar comprising D-psicose and D-allose and process for production of the same |
| JP5116071B2 (ja) * | 2005-07-20 | 2013-01-09 | 帝國製薬株式会社 | Ｄ−アロースおよびｄ−プシコースの抗神経因性疼痛効果の利用 |
| KR101339443B1 (ko) | 2005-11-15 | 2013-12-06 | 가부시기가이샤하야시바라 | 케토오스 3-에피머라아제와 그 제조 방법 및 용도 |
| WO2008059623A1 (en) * | 2006-11-10 | 2008-05-22 | Matsutani Chemical Industry Co., Ltd. | Sweetener containing d-psicose and foods and drinks obtained by using the same |
| KR20150015030A (ko) | 2007-05-18 | 2015-02-09 | 마쓰다니가가꾸고오교가부시끼가이샤 | 슈크로오스성 감미질을 가지는 신규 감미료, 그 제조법 및 용도 |
| EP2164460B1 (de) | 2007-06-06 | 2017-08-09 | Basf Se | Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten |
| CN101772304B (zh) | 2007-07-31 | 2014-07-09 | 卡吉尔公司 | 直接可压缩的右旋糖 |
| CN100577793C (zh) | 2007-12-12 | 2010-01-06 | 江南大学 | 微生物转化d-果糖制备d-阿洛酮糖的菌种和方法 |
| US9109266B2 (en) * | 2009-03-30 | 2015-08-18 | Matsutani Chemical Industry Co., Ltd. | Process of producing sugar composition comprising D-psicose and D-allose via strong alkaline isomerization of D-glucose/D-fructose or alkaline pre-treatment of D-glucose/D-fructose followed by isomerization in the presence of a basic ion exchange resin |
| KR101189640B1 (ko) | 2010-03-26 | 2012-10-12 | 씨제이제일제당 (주) | Ｄ-사이코스 결정을 제조하는 방법 |
| JP2011205913A (ja) | 2010-03-29 | 2011-10-20 | Kishoto Seisan Gijutsu Kenkyusho:Kk | 機能性異性化糖の複合体結晶糖質およびその製造方法 |
| JP5859191B2 (ja) | 2010-09-29 | 2016-02-10 | 松谷化学工業株式会社 | 高甘味度甘味料に対する呈味改良組成物およびその応用 |
| JP6099870B2 (ja) | 2012-01-06 | 2017-03-22 | 松谷化学工業株式会社 | スクロースとｄ−プシコースを含む新規甘味料 |
| CN102697744B (zh) * | 2012-05-29 | 2013-11-27 | 安吉东来药用辅料有限责任公司 | 阿洛糖片剂赋形剂、药物片剂及药物片剂的制备方法 |
| JP6581902B2 (ja) | 2013-04-26 | 2019-09-25 | 松谷化学工業株式会社 | エネルギー消費の促進および／またはエネルギー消費機能低下の治療および／または予防剤、または方法 |
| CN103333935A (zh) * | 2013-05-24 | 2013-10-02 | 桐乡晟泰生物科技有限公司 | D-阿洛酮糖的生产工艺 |
-
2015
- 2015-07-16 JP JP2017503611A patent/JP6803325B2/ja active Active
- 2015-07-16 EP EP15778704.5A patent/EP3171710B1/en active Active
- 2015-07-16 BR BR112017001192-1A patent/BR112017001192B1/pt active IP Right Grant
- 2015-07-16 SG SG11201700451QA patent/SG11201700451QA/en unknown
- 2015-07-16 ES ES15778704T patent/ES3060158T3/es active Active
- 2015-07-16 KR KR1020177000681A patent/KR102501024B1/ko active Active
- 2015-07-16 WO PCT/IB2015/001303 patent/WO2016012854A1/en not_active Ceased
- 2015-07-16 MX MX2017000827A patent/MX378866B/es unknown
- 2015-07-16 US US15/327,556 patent/US10342247B2/en active Active
- 2015-07-16 CN CN201580039823.8A patent/CN106535661B/zh active Active
- 2015-07-16 CA CA2955849A patent/CA2955849C/en active Active
-
2017
- 2017-01-18 CL CL2017000136A patent/CL2017000136A1/es unknown
-
2019
- 2019-05-29 US US16/425,014 patent/US20190289888A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017526651A5 (enExample) | ||
| JP2023503303A5 (enExample) | ||
| JP2023503309A5 (enExample) | ||
| JP2017178948A5 (enExample) | ||
| JP2016163571A5 (enExample) | ||
| FI3265084T3 (fi) | Brutonin tyrosiinikinaasin estäjän lääkeformulaatioita | |
| JP2012501986A5 (enExample) | ||
| JP2016540021A5 (enExample) | ||
| JP2021529829A5 (enExample) | ||
| JP2010522242A5 (enExample) | ||
| PE20061345A1 (es) | Composicion farmaceutica que comprende sorafenib | |
| CL2011000867A1 (es) | Formas cristalinas da, c y ii de (r)-5-[3-cloro-4-(2,3-dihidroxi-propoxi)- benz[z]ilideno]-2- ([z]- propilimino) -3-o- totil-tiazolidin-4-ona; composicion farmaceutica; y uso en el tratamiento o prevencion de rechazo de organos trasplantados, sindrome autoinmunitarios, asma, diabetes, cancer. | |
| JP2014221827A5 (enExample) | ||
| JP2016509051A5 (enExample) | ||
| JP2019510079A5 (enExample) | ||
| PH12017502325A1 (en) | Orodispersible dosage unit containing an estetrol component | |
| JP2009542678A5 (enExample) | ||
| JP2015537009A5 (enExample) | ||
| JP2016530291A5 (enExample) | ||
| JP2009541409A5 (enExample) | ||
| JP2021535175A5 (enExample) | ||
| RU2007107368A (ru) | Композиция, содержащая десмопрессин | |
| MY139086A (en) | Use of debranched starch in extrusion-spheronization pharmaceutical pellets | |
| NO20090262L (no) | Galeniske formuleringer av aliskiren og hydroklorotiazid | |
| JP2009505991A5 (enExample) |